Have a personal or library account? Click to login
Ultrasound-Guided Botulinum Toxin Infiltrations in Essential Tremor Patients: A 36-week Follow Up Cover

Ultrasound-Guided Botulinum Toxin Infiltrations in Essential Tremor Patients: A 36-week Follow Up

Tremor and Other Hyperkinetic Movements
Volume 15 (2025): Issue 1
By: Gabriel SalazarORCID and  Iolanda Caballero  
Open Access
|Mar 2025

References

  1. 1Ferrara J, Jankovic J. Epidemiology and management of essential tremor in children. Paediatr Drugs. 2009; 11(5): 293–307. DOI: 10.2165/11316050-000000000-00000
    Back to article
  2. 2Hopfner F, Deuschl G. Correction to: Managing Essential Tremor. Neurotherapeutics. 2021; 18(3): 2132. DOI: 10.1007/s13311-021-01131-5
    Back to article
  3. 3Louis ED. Clinical practice. Essential tremor. N Engl J Med. 2001; 345(12): 887–91. DOI: 10.1056/NEJMcp010928
    Back to article
  4. 4Louis ED. Essential Tremor. Handbook of the Cerebellum and Cerebellar Disorders. Cham: Springer; 2020. DOI: 10.1007/978-3-319-97911-3_99-2
    Back to article
  5. 5Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010; 25(5): 534–41. DOI: 10.1002/mds.22838
    Back to article
  6. 6Pan MK, Kuo SH. Essential tremor: Clinical perspectives and pathophysiology. J Neurol Sci. 2022; 435: 120198. DOI: 10.1016/j.jns.2022.120198
    Back to article
  7. 7Song P, Zhang Y, Zha M, Yang Q, Ye X, Yi Q, et al. The global prevalence of essential tremor, with emphasis on age and sex: A meta-analysis. J Glob Health. 2021; 11: 04028. DOI: 10.7189/jogh.11.04028
    Back to article
  8. 8Rajput AH, Rajput A. Medical treatment of essential tremor. J Cent Nerv Syst Dis. 2014; 6: 29–39. DOI: 10.4137/JCNSD.S13570
    Back to article
  9. 9Shanker V. Essential tremor: diagnosis and management. BMJ. 2019; 366: l4485. DOI: 10.1136/bmj.l4485
    Back to article
  10. 10Bain P, Brin M, Deuschl G, Elble R, Jankovic J, Findley L, et al. Criteria for the diagnosis of essential tremor. Neurology. 2000; 54(11 Suppl 4): S7.
    Back to article
  11. 11Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology. 1989; 39(12): 1587–8. DOI: 10.1212/WNL.39.12.1587
    Back to article
  12. 12Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001; 56(11): 1523–8. DOI: 10.1212/WNL.56.11.1523
    Back to article
  13. 13Findley LJK, W.C. Handbook of Tremor Disorders. 1st ed. Cambridge: CRC Press; 1994.
    Back to article
  14. 14Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord. 1996; 11(3): 250–6. DOI: 10.1002/mds.870110306
    Back to article
  15. 15Kupsch A, Benecke R, Muller J, Trottenberg T, Schneider GH, Poewe W, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006; 355(19): 1978–90. DOI: 10.1056/NEJMoa063618
    Back to article
  16. 16Pahwa R, Lyons KE, Wilkinson SB, Simpson RK, Jr., Ondo WG, Tarsy D, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006; 104(4): 506–12. DOI: 10.3171/jns.2006.104.4.506
    Back to article
  17. 17Sheffield JK, Jankovic J. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson’s disease. Expert Rev Neurother. 2007; 7(6): 637–47. DOI: 10.1586/14737175.7.6.637
    Back to article
  18. 18Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol. 2011; 10(2): 148–61. DOI: 10.1016/S1474-4422(10)70322-7
    Back to article
  19. 19Elias WJ, Lipsman N, Ondo WG, Ghanouni P, Kim YG, Lee W, et al. A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. N Engl J Med. 2016; 375(8): 730–9. DOI: 10.1056/NEJMoa1600159
    Back to article
  20. 20Lozano AM, Lang AE, Galvez-Jimenez N, Miyasaki J, Duff J, Hutchinson WD, et al. Effect of GPi pallidotomy on motor function in Parkinson’s disease. Lancet. 1995; 346(8987): 1383–7. DOI: 10.1016/S0140-6736(95)92404-3
    Back to article
  21. 21Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum toxin in essential hand tremor – A randomized double-blind placebo-controlled study with customized injection approach. Parkinsonism Relat Disord. 2018; 56: 65–9. DOI: 10.1016/j.parkreldis.2018.06.019
    Back to article
  22. 22Jog M, Lee J, Scheschonka A, Chen R, Ismail F, Boulias C, et al. Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study. Toxins (Basel). 2020; 12(12). DOI: 10.3390/toxins12120807
    Back to article
  23. 23Mittal SO, Lenka A, Jankovic J. Botulinum toxin for the treatment of tremor. Parkinsonism Relat Disord. 2019; 63: 31–41. DOI: 10.1016/j.parkreldis.2019.01.023
    Back to article
  24. 24Salazar G, Ferreiro S, Fragoso M, Codas J, Cruz H. Ultrasound and Electromyography as Guidance Tools for the Botulinum Toxin Therapy in Cervical Dystonia. Journal of Behavioral and Brain Science. 2021; 11(02): 49–57. DOI: 10.4236/jbbs.2021.112004
    Back to article
  25. 25Walter U. Muscle Ultrasound in Clinical Neurology: Diagnostic Uses and Guidance of Botulinum Toxin Injection. Journal of Neurosonology and Neuroimaging. 2023; 15(1): 38–53. DOI: 10.31728/jnn.2023.00133
    Back to article
  26. 26Walter U, Dressler D. Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Rev Neurother. 2014; 14(8): 923–36. DOI: 10.1586/14737175.2014.936387
    Back to article
  27. 27Alter KE, Karp BI. Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures. Toxins (Basel). 2017; 10(1): 18. DOI: 10.3390/toxins10010018
    Back to article
  28. 28Asimakidou E, Sidiropoulos C. A Bayesian Network Meta-Analysis and Systematic Review of Guidance Techniques in Botulinum Toxin Injections and Their Hierarchy in the Treatment of Limb Spasticity. Toxins (Basel). 2023; 15(4): 256. DOI: 10.3390/toxins15040256
    Back to article
  29. 29Ramirez-Castaneda J, Jankovic J, Comella C, et al. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013; 28(13): 1775–83. DOI: 10.1002/mds.25582
    Back to article
  30. 30Henzel MK, Munin MC, Niyonkuru C, Skidmore ER, Weber DJ, Zafonte RD. Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections. PM R. 2010; 2(7): 642–646. DOI: 10.1016/j.pmrj.2010.05.002
    Back to article
  31. 31Narouze SN, Provenzano D, Peng P, et al. The American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, and the Asian Australasian Federation of Pain Societies Joint Committee recommendations for education and training in ultrasound-guided interventional pain procedures. Reg Anesth Pain Med. 2012; 37(6): 657–664. DOI: 10.1097/AAP.0b013e318269c189
    Back to article
  32. 32Warrick P, Dromey C, Irish J, Durkin L. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. J Voice. 2000; 14(3): 410–21.27. DOI: 10.1016/S0892-1997(00)80086-7
    Back to article
DOI: https://doi.org/10.5334/tohm.957 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 4, 2024
Accepted on: Jan 25, 2025
Published on: Mar 3, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
essential tremor,
botulinum toxin,
ultrasound guidance

© 2025 Gabriel Salazar, Iolanda Caballero, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 15 (2025): Issue 1Next article